Apple celebrates a significant victory in a long-standing patent dispute with the medical technology company Masimo. A US court in Washington has lifted a sales ban on certain models of the popular Apple Watches. The dispute revolves around features of the electronic wristwatches that can measure blood oxygen levels and allegedly infringe on Masimo's patent rights.

Apple and Masimo have already had several lawsuits against each other. Most recently, the US trade authority International Trade Commission imposed an import ban on the two controversial models, Apple Watch Series 9 and Apple Watch Ultra 2. This was enforced on Tuesday with the government's approval.

The Appeals Court in Washington now decided, at the request of Apple in an expedited procedure, that the company is allowed to sell the two watch models again in the USA for the time being. Masimo had accused Apple of violating patents with certain functions of the watches. These measurement functions are particularly popular among consumers and are used as an important selling point for the models.

The court's decision in Washington is a major victory for Apple, who were fearing significant financial losses due to the sale of controversial watch models. The US corporation is now allowed, at least for the time being, to continue distributing the popular models in the USA and thus securing important revenues.

However, whether this means the end of the dispute between Apple and Masimo remains to be seen. Both companies continue to fight for the rights to the patented functions and it is unclear whether there will be a long-term agreement or even a continuation of the legal proceedings.

In the meantime, Apple and its shareholders can celebrate this important victory in the long-standing patent dispute. The court's decision strengthens the company's position and shows that Apple is capable of successfully defending itself against competitors' patent claims. For investors, this could be a positive signal for the future and lead to rising stock prices.